Angela Fields, DPM, joined Mimbres Memorial Hospital's Deming (N.M.) Podiatry Services, according to a Deming Headlight report.
Orthopedic
Michael Joyce, MD, is the co-director of the musculoskeletal tumor center at Cleveland Clinic. His practice focuses on musculoskeletal tumors, adult reconstructive arthritis procedures and difficult fracture treatment. He is one of two trained orthopedic traumatologists at Cleveland Clinic.
Researchers analyzed recent trends in the incidence and treatment of proximal humerus fractures in a cross-sectional elderly population. Investigators analyzed Medicare data from 2005 to 2012 and looked at patient demographics, hospitalization data, treatment and revision status.
Building Owners Management Association Greater Minneapolis named TRIA Orthopaedic Center in Bloomington, Minn., outstanding building of the year in the medical office category, according to a Sun Current report.
Geisinger Medical Center earns Blue Distinction Center designation for knee, hip surgeries — 3 notes
Highmark Blue Shield named Danville, Pa.-based Geisinger Medical Center a Blue Distinction Center for Knee and Hip Replacement, according to The Daily Item.
Advertisement
A study presented at the 2016 Annual Meeting of the American Academy of Orthopaedic Surgeons found patients who performed prescribed exercises at home without a physical therapist progressed comparably as those who received physical therapy at an outpatient facility, as…
In a study published in the Journal of Shoulder and Elbow Surgery, researchers found patients who were malnourished prior to total shoulder arthroplasty experienced a significantly increased risk for blood transfusion, longer hospital stay and death within 30 days of…
Keith Watson, MD, is an orthopedic surgeon with Orthopedic Specialty Associates in Fort Worth, Texas.
Mount Auburn Hospital in Cambridge, Mass., plans to open its new Longfellow Center for Joint Replacement on April 4.
Steven W. Meier, MD, an orthopedic surgeon practicing in Beverly Hills, Calif., discussed projections that the field for stem cell treatment and regenerative medicine will grow to $24 billion by 2017.